Health Care & Life Sciences » Pharmaceuticals | Chong Kun Dang Pharmaceutical Corp.

Chong Kun Dang Pharmaceutical Corp. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,417
35,154
6,773
40,946
53,728
41,704
Depreciation, Depletion & Amortization
3,280
20,548
22,677
23,848
21,900
21,136
Other Funds
1,152
14,852
18,069
29,169
27,644
21,226
Funds from Operations
8,849
70,554
33,974
93,963
103,272
84,066
Changes in Working Capital
1,111
5,751
26,712
36,177
21,599
41,438
Net Operating Cash Flow
9,960
64,803
7,261
57,786
81,673
42,628
Capital Expenditures
2,119
21,324
35,673
39,439
21,322
Sale of Fixed Assets & Businesses
175
88
58
10
324
Purchase/Sale of Investments
448
4,553
664
4,269
3,209
Net Investing Cash Flow
2,391
25,789
35,930
43,398
23,880
Cash Dividends Paid - Total
-
2,821
7,523
5,642
8,463
Issuance/Reduction of Debt, Net
-
-
-
-
26,268
Net Financing Cash Flow
384
2,821
7,523
5,642
34,731
Net Change in Cash
7,167
35,826
35,928
8,868
23,750
Free Cash Flow
8,103
46,066
24,973
19,863
61,884
Other Sources
-
1
350
300
328
Change in Capital Stock
384
-
-
-
-
Exchange Rate Effect
17
367
263
122
689

About Chong Kun Dang Pharmaceutical

View Profile
Address
8 Chungjeong-ro
Seoul SL 03742
Korea, Republic Of
Employees -
Website http://www.ckdpharm.com
Updated 07/08/2019
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetic, antivirus, beta-blocking, anti-hyperlipidemia and others. The company was founded on November 2, 2013 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.